ALB and biliary liver cirrhosis: Hyperbilirubinemia (serum total bilirubin 0.5 vs. 1.9 mg/dl in the GSD and BA groups, respectively; P = 0.001) and hypoalbuminemia (serum albumin 4.2 vs. 3.8 g/dL, respectively; P = 0.013) can be explained by the underlying pathophysiologic course of BA, wherein the main clinical outcome in patients include obstructive jaundice and subsequent biliary cirrhosis.